Machine Learning in Drug Metabolism Study

被引:3
作者
Sinha, Krishnendu [1 ]
Ghosh, Jyotirmoy [2 ]
Sil, Parames Chandra [3 ,4 ]
机构
[1] Jhargram Raj Coll, Dept Zool, Jhargram 721507, India
[2] Banwarilal Bhalotia Coll, Dept Chem, Asansol 713303, India
[3] Bose Inst, Dept Div Mol Med, Kolkata 700054, India
[4] Bose Inst, Div Mol Med, Kolkata 700054, India
关键词
Machine learning; algorithms; deep learning; drug metabolism; metabolites; molecular docking; PHASE-I; PREDICTION; FUTURE; MECHANISMS; DISCOVERY; TOXICITY; NETWORK; MODELS; WEB;
D O I
10.2174/1389200224666221227094144
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Metabolic reactions in the body transform the administered drug into metabolites. These metabolites exhibit diverse biological activities. Drug metabolism is the major underlying cause of drug overdose-related toxicity, adversative drug effects and the drug's reduced efficacy. Though metabolic reactions deactivate a drug, drug metabolites are often considered pivotal agents for off-target effects or toxicity. On the other side, in combination drug therapy, one drug may influence another drug's metabolism and clearance and is thus considered one of the primary causes of drug-drug interactions. Today with the advancement of machine learning, the metabolic fate of a drug candidate can be comprehensively studied throughout the drug development procedure. Naive Bayes, Logistic Regression, k-Nearest Neighbours, Decision Trees, different Boosting and Ensemble methods, Support Vector Machines and Artificial Neural Network boosted Deep Learning are some machine learning algorithms which are being extensively used in such studies. Such tools are covering several attributes of drug metabolism, with an emphasis on the prediction of drug-drug interactions, drug-target-interactions, clinical drug responses, metabolite predictions, sites of metabolism, etc. These reports are crucial for evaluating metabolic stability and predicting prospective drug-drug interactions, and can help pharmaceutical companies accelerate the drug development process in a less resource-demanding manner than what in vitro studies offer. It could also help medical practitioners to use combinatorial drug therapy in a more resourceful manner. Also, with the help of the enormous growth of deep learning, traditional fields of computational drug development like molecular interaction fields, molecular docking, quantitative structure-to-activity relationship (QSAR) studies and quantum mechanical simulations are producing results which were unimaginable couple of years back. This review provides a glimpse of a few contextually relevant machine learning algorithms and then focuses on their outcomes in different studies.
引用
收藏
页码:1012 / 1026
页数:15
相关论文
共 50 条
  • [41] Machine Learning in High-Alert Medication Treatment: A Study on the Cardiovascular Drug
    Tai, Chun-Tien
    Sue, Kuen-Liang
    Hu, Ya-Han
    [J]. APPLIED SCIENCES-BASEL, 2020, 10 (17):
  • [42] Remodelling structure-based drug design using machine learning
    Dutta, Shubhankar
    Bose, Kakoli
    [J]. EMERGING TOPICS IN LIFE SCIENCES, 2021, 5 (01) : 13 - 27
  • [43] Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics
    Koromina, Maria
    Pandi, Maria-Theodora
    Patrinos, George P.
    [J]. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2019, 23 (11) : 539 - 548
  • [44] Drug Target Identification with Machine Learning: How to Choose Negative Examples
    Najm, Matthieu
    Azencott, Chloe-Agathe
    Playe, Benoit
    Stoven, Veronique
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (10)
  • [45] A combined drug discovery strategy based on machine learning and molecular docking
    Zhang, Yanmin
    Wang, Yuchen
    Zhou, Weineng
    Fan, Yuanrong
    Zhao, Junnan
    Zhu, Lu
    Lu, Shuai
    Lu, Tao
    Chen, Yadong
    Liu, Haichun
    [J]. CHEMICAL BIOLOGY & DRUG DESIGN, 2019, 93 (05) : 685 - 699
  • [46] Recent progress in machine learning approaches for predicting carcinogenicity in drug development
    Le, Nguyen Quoc Khanh
    Tran, Thi-Xuan
    Nguyen, Phung-Anh
    Ho, Trang-Thi
    Nguyen, Van-Nui
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2024, 20 (07) : 621 - 628
  • [47] Predicting Drug-Induced Liver Injury with Bayesian Machine Learning
    Williams, Dominic P.
    Lazic, Stanley E.
    Foster, Alison J.
    Semenova, Elizaveta
    Morgan, Paul
    [J]. CHEMICAL RESEARCH IN TOXICOLOGY, 2020, 33 (01) : 239 - 248
  • [48] Machine Learning-Enabled Drug-Induced Toxicity Prediction
    Bai, Changsen
    Wu, Lianlian
    Li, Ruijiang
    Cao, Yang
    He, Song
    Bo, Xiaochen
    [J]. ADVANCED SCIENCE, 2025,
  • [49] In silico drug discovery: a machine learning-driven systematic review
    Atasever, Sema
    [J]. MEDICINAL CHEMISTRY RESEARCH, 2024, 33 (09) : 1465 - 1490
  • [50] From machine learning to deep learning: progress in machine intelligence for rational drug discovery
    Zhang, Lu
    Tan, Jianjun
    Han, Dan
    Zhu, Hao
    [J]. DRUG DISCOVERY TODAY, 2017, 22 (11) : 1680 - 1685